On the regional and specific serotonin uptake inhibition by LM 5008.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011976:Receptors, Muscarinic / Q000187:drug effects; D012453:Saimiri; D012701:Serotonin / Q000378:metabolism*; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D007211:Indoles; D010276:Parasympatholytics; D010880:Piperidines; D011976:Receptors, Muscarinic; D005473:Fluoxetine; D012701:Serotonin; C018181:indalpine; D004298:Dopamine; D009638:Norepinephrine